Defibrillator (AICD) Clinical Trials

Since 2002, wearable cardioverter defibrillators (WCD) have been approved for use in the USA and Europe to prevent sudden death due to rapid abnormal rhythms of the heart. In this particular model, more data is collected and additional options are available that may help in the monitoring and treatment of ...

The purpose of this post-approval registry is to confirm the safety and reliability of the Protego lead as used in conjunction with any compatible BIOTRONIK Ilesto or future US market released DF4 ICD or CRT-D device. Data will be collected from up to 1694 subjects from implant through 5 years ...

Medtronic, Inc. is sponsoring the World-wide Randomized Antibiotic EnveloPe Infection PrevenTion Trial (WRAP-IT), a randomized, prospective, multi-center, single blinded, post market, interventional clinical study. The study has three purposes. First, the WRAP-IT study will serve as a post-approval study for those geographies requiring a post-approval study to facilitate collection of ...

Study length: 6 years

This research study is investigating a medical device called the ZOLL Short-term use Wearable Defibrillator (“SWD 1000”).  A defibrillator is a device used to control an abnormal heart beat by applying an electric current, also known as "shocking", to the chest wall or heart. We are asking you to take ...